This round table session brings together experts in the field of personalized medicine and associate pharmacogenetic issues that currently dominate future of clinical management in the context of the molecular concepts of medicine. Audience will be updated on future trends by academic experts as well as industry.

Specific emphasis will be given to gene polymorphism and the impact of cytochrome transporter and genepolymorthism of urinary tract therapy.

The conceptual links between sex-gene-drug interactions, with particular emphasis in fluid balance and enuresis will be updated from a particularly practical platform.